SB 1724 — Missouri
Makes xylazine a Schedule III controlled substance
This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.
Missouri legislative agenda & upcoming votes Missouri session calendar
Summary
SB 1724 - This act makes xylazine a Schedule III controlled substance, except for certain uses described in the act, including manufacturing a drug for an animal or administering the drug to an animal.
This act is substantially similar to HB 1881 (2026).
SARAH HASKINS
- SB 1724 is a bill in the Missouri Senate, 2026 session, introduced February 25, 2026.
- Sponsored by Justin Brown.
- Current status: introduced.
- Most recent action (May 7, 2026): Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee.
- Subjects: Animals, Drugs and Controlled Substances, Pharmacy, Veterinarians.
-
State Senator, District 16
Republican
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Justin Brown
History
- Introduced, completed
- Passed Senate, in progress
- Passed House, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate S First Read
- Senate Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee Latest